-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q2 2020 to Q3 2025.
- Cytek Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was -$2,291,000.000, a 192% decline year-over-year.
- Cytek Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$2,667,000.000, a 52.2% decline year-over-year.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2024 was $320,000.000.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3,561,000.000, a 191% decline from 2022.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1,224,000.000, a 142% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)